Sales & Marketing Sponsored 12 Questions with Michael Stevinson Michael Stevinson is Global Agency Head at Caudex, an IPG Health Medical Communications company.
Views & Analysis Scientific evidence ‘on demand’? Proceedings from an expert ... The ways in which we communicate and consume information are constantly transforming.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
